Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation
Published on: August 30, 2024
Is steroids therapy effective in treating phimosis? A meta-analysis
Jiaming Liu1, Jin Yang2, Yuntian Chen3
1Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Insights
Topical steroid therapy is more effective for treating childhood phimosis than placebo or manual reduction. This systematic review provides evidence for clinical options before circumcision.
Area of Science:
- Pediatric Urology
- Dermatology
- Evidence-Based Medicine
Background:
- Phimosis is a common condition in pediatric patients.
- Treatment options for phimosis include topical steroids, manual reduction, and circumcision.
- The efficacy of topical steroids requires systematic evaluation.
Purpose of the Study:
- To systematically review the therapeutic efficacy of topical steroids in children with phimosis.
- To provide data supporting clinical decisions for pediatric phimosis management.
- To compare topical steroid therapy with placebo and manual reduction.
Main Methods:
- Systematic review of original studies on topical steroid therapy for pediatric phimosis.
- Searched literature up to August 2014.
- Meta-analysis performed using REVMAN 5.2 software with quality assessment via Cochrane handbook.
Main Results:
- Eleven studies with 1669 patients were included.
- Topical steroids showed significantly higher efficacy compared to placebo or manual reduction (OR 7.46, p < 0.00001).
- Subgroup analyses confirmed significant efficacy against both placebo (OR 5.04, p < 0.00001) and manual reduction (OR 16.28, p < 0.00001).
Conclusions:
- Topical steroid therapy is a more effective treatment for pediatric phimosis than placebo or manual reduction.
- Topical steroids can be considered as a treatment option prior to circumcision.
- Further research may be needed to determine optimal steroid types and dosages.
Purpose:
We evaluated a systematic review on the therapeutic efficacy of topical steroids in children with phimosis to provide data for the clinical options of pediatric phimosis.
Methods:
We searched the related original studies on topical steroid therapy in pediatric phimosis before August 2014. Two reviewers independently performed the study selection, data extraction, risk of bias and reporting quality assessment with confirmation by cross-checking. The quality of eligible studies was appraised with the 'Cochrane handbook.' The meta-analysis was performed by REVMAN 5.2 software.
Results:
Eleven studies were included with 1669 patients among which 1093 received topical steroids and 576 cases treated with placebo or only manual reduction. Significant difference of the treatment efficacy was detected among the three methods [OR 7.46, 95 % CI (4.42, 12.58), p < 0.00001]. In subgroup analysis, significant difference of the treatment efficacy was also detected whether with placebo or manual reduction only [respectively, OR 5.04, 95 % CI (3.19, 7.95), p < 0.00001; OR 16.28, 95 % CI (6.06, 43.69), p < 0.00001].
Conclusions:
Compared to the placebo or manual reduction method, the topical steroid therapy is more effective in the treatment of phimosis in children. Although there is still controversy in the different type and dosage of steroid, this could be used against phimosis before circumcision.
More Related Videos
03:06Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles
Published on: December 22, 2023
09:49Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
Related Concept Videos
Acne Infection
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...